ISSN 2398-2950      

Therapeutics: musculoskeletal system

ffelis

Introduction

  • This section will cover the pharmacological effects of non-steroidal anti-inflammatory drugs (NSAIDs), other joint modifying agents, topical anti-inflammatory agents, cytotoxic immunosuppressants and disease-modifying drugs, and other oral analgesics to control musculoskeletal pain in cats. 

Non-steroidal anti-inflammatory drugs (NSAIDs)

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Other anti-inflammatory drugs

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Topical anti-inflammatory preparations

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Cytotoxic immunosuppressants and disease-modifying drugs

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Other oral analgesics used to control musculoskeletal pain in cats

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Kongara K, Chambers J P (2018) Robenacoxib in the treatment of pain in cats and dogs: safety, efficacy, and place in therapy. Vet Med (Auckl) 9, 53-61 PubMed Full Article.
  • KuKanich B (2013) Outpatient Oral Analgesics in Dogs and Cats Beyond Nonsteroidal Antiinflammatory Drugs: An Evidence-based Approach. Vet Clin North Am Small Anim Pract 43 (5), 1109-1125 PubMed.
  • Gunew M N, Menrath V H, Marshall R D (2008) Long-term safety, efficacy and palatability of oral meloxicam at 0.01-0.03 mg/kg for treatment of osteoarthritic pain in cats. J Feline Med Surg 10 (3), 235-241 PubMed.
  • Gassel A D, Tobias K M & Cox S K (2006) Disposition of deracoxib in cats after oral administration. JAAHA 42 (3), 212-217 PubMed.
  • McCann M E, Rickes E L, Hora D F et al (2005) In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia. Am J Vet Res 66 (7), 1278-1284 PubMed.
  • Behrend E N, Kemppainen R J (1997) Glucocorticoid therapy. Pharmacology, indications, and complications. Vet Clin North Am Small Anim Pract 27 (2), 187-213 PubMed.

Can’t find what you’re looking for?

We have an ever growing content library on Vetlexicon so if you ever find we haven't covered something that you need please fill in the form below and let us know!

 
 
 
 

To show you are not a Bot please can you enter the number showing adjacent to this field

 Security code